Minimally Invasive Bi-Atrial Lesion Pattern Produces Positive Results In Patients With Atrial Fibrillation Interim results from a study conducted in patients with atrial fibrillation demonstrated that a port access, paracardioscopic Ex-Maze procedure produced favorable outcomes and allowed patients to discontinue antiarrhythmic
drugs. Andy C. Kiser, MD, presented the results in a poster session at the American College of Cardiology meeting in Chicago.
Source: www.medicalnewstoday.comCarl Zeiss Meditec Delivers Key Technological Advances In Optical Coherence Tomography Carl Zeiss Meditec, a leader in ophthalmic devices and surgical systems, announced today that two new optical coherence tomography (OCT) applications will be available for the first time at the American Society of Cataract and Refractive Surgeons (ASCRS) meeting in Chicago, IL at booth 2028.
Source: www.medicalnewstoday.comMolecule's 'Dark Side' Can Trigger Cancer Cancer Research UK scientists have discovered that a common molecule previously known to play a fundamental role in building protein, can also trigger cancer. The surprise findings are published in Cell*.
Source: www.medicalnewstoday.comPatients Help Crack Nurses' And Midwives' Code, UK To mark World
Health Day, the Nursing & Midwifery Council (NMC) today launches a new Code for the UK's 674,000 nurses and midwivesWith events held in Edinburgh, Belfast, Glamorgan and London, the launch of the new Code aims to clarify expectations; setting out for nurses and midwives what is expe
Source: www.medicalnewstoday.comMinority Physicians Underrepresented In California, Study Finds While blacks and Hispanics make up 40% of California's population, fewer than 10% of practicing physicians are black or Hispanic, according to a report released on Wednesday by the University of California-San Francisco Center for California
Health Workforce Studies, the San Francisco Chronicle reports (Fernandez, San Francisco Chronicle, 4/3).
Source: www.medicalnewstoday.comVIVUS Enters Into 30 Million Dollars Funding Collaboration For The Phase 3 Studies Of Avanafil For Erectile Dysfunction VIVUS, Inc. (NASDAQ: VVUS) announced that it has entered into a $30 million funding collaboration with Deerfield Management ("Deerfield"). Under the terms of the agreements, Deerfield will provide funds for the phase 3 program for avanafil, a fast-acting, highly selective, phosphodiesterase type 5 inhibitor (PDE5i) for the treatment of erectile dysfunction (ED).
Source: www.medicalnewstoday.comFederal Agents Seize Nearly 1.3 Million Dollars Of Illegal Dietary Supplements At the request of the U.S. Food and Drug Administration, on Wednesday U.S. Marshals seized more than $1,301,712 of dietary supplements from LG Sciences, LLC, of Brighton, Mich., because the products contain unapproved food additives and/or new dietary ingredients that cause the products to violate the law. Labeled as dietary supplements, the products are marketed for use by body builders.
Source: www.medicalnewstoday.com
# posted by Network @ 4:00 PM
